Francesco Albano Selected Research

Imatinib Mesylate (Gleevec)

1/2021	Perspectives and Emotional Experiences of Patients With Chronic Myeloid Leukemia During ENESTPath Clinical Trial and Treatment-Free Remission: Rationale and Protocol of the Italian Substudy.
8/2017	The BCR-ABL1 transcript type influences response and outcome in Philadelphia chromosome-positive chronic myeloid leukemia patients treated frontline with imatinib.
1/2017	Incidence of second primary malignancies and related mortality in patients with imatinib-treated chronic myeloid leukemia.
4/2016	Next-generation sequencing for sensitive detection of BCR-ABL1 mutations relevant to tyrosine kinase inhibitor choice in imatinib-resistant patients.
1/2016	Rotation of nilotinib and imatinib for first-line treatment of chronic phase chronic myeloid leukemia.
1/2013	Impact of BCR-ABL mutations on response to dasatinib after imatinib failure in elderly patients with chronic-phase chronic myeloid leukemia.
6/2010	Deletions of the derivative chromosome 9 do not influence the response and the outcome of chronic myeloid leukemia in early chronic phase treated with imatinib mesylate: GIMEMA CML Working Party analysis.
4/2007	Late-appearing pseudocentric fission event during chronic myeloid leukemia progression.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Francesco Albano Research Topics

Disease

24	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 11/2023 - 04/2007
21	Neoplasms (Cancer) 03/2023 - 10/2008
13	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2023 - 03/2008
11	Leukemia 01/2022 - 03/2013
9	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 03/2024 - 03/2002
7	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 12/2021 - 10/2004
6	Hematologic Neoplasms (Hematological Malignancy) 05/2023 - 06/2010
6	Philadelphia Chromosome 01/2021 - 08/2017
5	Residual Neoplasm 01/2023 - 10/2004
5	Acute Promyelocytic Leukemia 01/2021 - 02/2017
4	Melanoma (Melanoma, Malignant) 09/2020 - 04/2013
4	Lymphoma (Lymphomas) 01/2019 - 09/2014
3	Eosinophilia 02/2022 - 11/2019
3	Disease Progression 12/2021 - 10/2017
2	Cardiovascular Diseases (Cardiovascular Disease) 11/2023 - 01/2020
2	Carcinoma (Carcinomatosis) 03/2023 - 09/2020
2	Inflammation (Inflammations) 01/2023 - 09/2015
2	Hematologic Diseases (Blood Diseases) 01/2022 - 12/2019
2	Graft vs Host Disease (Graft-Versus-Host Disease) 11/2021 - 03/2013
2	B-Cell Lymphoma (Lymphoma, B Cell) 09/2020 - 01/2016
2	Multiple Myeloma 09/2020 - 10/2017
2	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 09/2020 - 01/2015
2	Non-Hodgkin Lymphoma (Lymphosarcoma) 03/2020 - 01/2020
2	Genetic Translocation (Chromosomal Translocation) 09/2014 - 10/2008
2	Mitochondrial Diseases (Mitochondrial Disease) 04/2013 - 01/2010
1	VEXAS syndrome 12/2023
1	Anemia 12/2023
1	Chronic Disease (Chronic Diseases) 12/2023
1	Fatigue 12/2023
1	Thalassemia 10/2023
1	Infections 09/2023
1	COVID-19 09/2023
1	Porcine Reproductive and Respiratory Syndrome (PRRS) 03/2023
1	Thrombosis (Thrombus) 10/2022
1	Polycythemia (Erythrocytosis) 08/2022
1	Pheochromocytoma 05/2022
1	Chromosome Aberrations (Chromosome Abnormalities) 02/2022
1	Chondrosarcoma 01/2022
1	Breast Neoplasms (Breast Cancer) 01/2022
1	Myeloid Leukemia (Leukemia, Myelocytic) 01/2022
1	Leiomyosarcoma 01/2022
1	Iatrogenic Disease 01/2022
1	Bronchiolitis Obliterans Syndrome 01/2022
1	Aggressive Fibromatosis (Desmoid) 01/2022
1	Hemangiosarcoma (Angiosarcoma) 01/2022
1	Head and Neck Neoplasms (Head and Neck Cancer) 01/2022

Drug/Important Bio-Agent (IBA)

17	Tyrosine Kinase InhibitorsIBA 01/2023 - 03/2013
8	nilotinib FDA Link 11/2023 - 03/2013
8	Imatinib Mesylate (Gleevec)FDA Link 01/2021 - 04/2007
4	ponatinibIBA 11/2023 - 01/2019
4	Phosphotransferases (Kinase)IBA 01/2021 - 01/2013
4	Dasatinib (BMS 354825)FDA Link 01/2019 - 01/2013
3	Proteins (Proteins, Gene)FDA Link 03/2023 - 10/2014
3	Biomarkers (Surrogate Marker)IBA 07/2021 - 10/2017
3	fludarabineIBA 11/2020 - 02/2014
3	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2020 - 02/2017
2	ibrutinibIBA 03/2024 - 01/2022
2	Hemoglobins (Hemoglobin)IBA 12/2023 - 08/2022
2	Transcription Factors (Transcription Factor)IBA 02/2023 - 01/2014
2	Interferon Regulatory FactorsIBA 01/2023 - 12/2021
2	ruxolitinibIBA 10/2022 - 01/2017
2	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 02/2022 - 01/2021
2	Platelet-Derived Growth Factor beta Receptor (Receptor, Platelet Derived Growth Factor beta)IBA 02/2022 - 02/2008
2	LDL Lipoproteins (beta Lipoproteins)IBA 08/2021 - 01/2020
2	MicroRNAs (MicroRNA)IBA 07/2021 - 08/2012
2	Arsenic Trioxide (Trisenox)FDA Link 01/2020 - 02/2017
2	Peptides (Polypeptides)IBA 10/2017 - 01/2016
2	Untranslated RNA (Noncoding RNA)IBA 10/2015 - 10/2008
2	AntigensIBA 12/2014 - 03/2002
2	Caspase 3 (Caspase-3)IBA 10/2014 - 04/2013
2	Diclofenac (SR 38)FDA LinkGeneric 04/2013 - 01/2010
2	Superoxide DismutaseIBA 04/2013 - 01/2010
1	luspaterceptIBA 10/2023
1	DNA (Deoxyribonucleic Acid)IBA 05/2023
1	NLR ProteinsIBA 03/2023
1	NucleotidesIBA 03/2023
1	Pattern Recognition ReceptorsIBA 03/2023
1	InflammasomesIBA 03/2023
1	ribonucleotide polymeraseIBA 01/2023
1	Rituximab (Mabthera)FDA Link 01/2023
1	venetoclaxIBA 01/2023
1	Janus Kinase InhibitorsIBA 10/2022
1	TESIBA 10/2022
1	Hydroxyurea (Hydrea)FDA LinkGeneric 10/2022
1	CatecholaminesIBA 05/2022
1	3-Iodobenzylguanidine (Iobenguane)IBA 05/2022
1	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 02/2022
1	fms-Like Tyrosine Kinase 3IBA 01/2022
1	Antiviral Agents (Antivirals)IBA 01/2022
1	Messenger RNA (mRNA)IBA 01/2022

Therapy/Procedure

25	Therapeutics 12/2023 - 03/2008
6	Drug Therapy (Chemotherapy) 01/2022 - 01/2016
3	Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation) 01/2022 - 03/2013
3	Precision Medicine 12/2021 - 10/2017
3	Transplantation 11/2021 - 03/2013
3	Aftercare (After-Treatment) 01/2020 - 04/2007
2	Ligation 05/2023 - 03/2008
2	Bridge Therapy 01/2023 - 11/2017
1	Radiotherapy 01/2022
1	Radiofrequency Ablation 01/2022